Mouillac B - Search Results

1

Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.

Albizu L, Teppaz G, Seyer R, Bazin H, Ansanay H, Manning M, Mouillac B, Durroux T. Albizu L, et al. Among authors: mouillac b. J Med Chem. 2007 Oct 4;50(20):4976-85. doi: 10.1021/jm061404q. Epub 2007 Sep 12. J Med Chem. 2007. PMID: 17850055

2

The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.

Mouillac B, Chini B, Balestre MN, Elands J, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Jard S, Barberis C. Mouillac B, et al. J Biol Chem. 1995 Oct 27;270(43):25771-7. doi: 10.1074/jbc.270.43.25771. J Biol Chem. 1995. PMID: 7592759 Free article.

3

Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.

Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, et al. Chini B, et al. Among authors: mouillac b. EMBO J. 1995 May 15;14(10):2176-82. doi: 10.1002/j.1460-2075.1995.tb07211.x. EMBO J. 1995. PMID: 7774575 Free PMC article.

4

Identification of agonist binding sites of vasopressin and oxytocin receptors.

Mouillac B, Chini B, Balestre MN, Jard S, Barberis C, Manning M, Tribollet E, Trumpp-Kallmeyer S, Hoflack J, Elands J, et al. Mouillac B, et al. Adv Exp Med Biol. 1995;395:301-10. Adv Exp Med Biol. 1995. PMID: 8713980

5

Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.

Chini B, Mouillac B, Ala Y, Balestre MN, Cotte N, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, et al. Chini B, et al. Among authors: mouillac b. Adv Exp Med Biol. 1995;395:321-8. Adv Exp Med Biol. 1995. PMID: 8713982

6

Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors.

Chini B, Mouillac B, Ala Y, Balestre MN, Trumpp-Kallmeyer S, Hoflack J, Elands J, Hibert M, Manning M, Jard S, Barberis C. Chini B, et al. Among authors: mouillac b. Ann N Y Acad Sci. 1997 May 30;812:218-21. doi: 10.1111/j.1749-6632.1997.tb48181.x. Ann N Y Acad Sci. 1997. PMID: 9186749 No abstract available.

7

Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors.

Ala Y, Morin D, Mahé E, Cotte N, Mouillac B, Jard S, Barberis C, Tribollet E, Dreifuss JJ, Sawyer WH, Wo NC, Chan WY, Kolodziejczyk AS, Cheng LL, Manning M. Ala Y, et al. Among authors: mouillac b. Eur J Pharmacol. 1997 Jul 23;331(2-3):285-93. doi: 10.1016/s0014-2999(97)01021-2. Eur J Pharmacol. 1997. PMID: 9274991 Free article.

8

Efficient photoaffinity labeling of the rat V1a vasopressin receptor using a linear azidopeptidic antagonist.

Carnazzi E, Aumelas A, Phalipou S, Mouillac B, Guillon G, Barberis C, Seyer R. Carnazzi E, et al. Among authors: mouillac b. Eur J Biochem. 1997 Aug 1;247(3):906-13. doi: 10.1111/j.1432-1033.1997.00906.x. Eur J Biochem. 1997. PMID: 9288914 Free article.

9

Mapping peptide-binding domains of the human V1a vasopressin receptor with a photoactivatable linear peptide antagonist.

Phalipou S, Cotte N, Carnazzi E, Seyer R, Mahe E, Jard S, Barberis C, Mouillac B. Phalipou S, et al. Among authors: mouillac b. J Biol Chem. 1997 Oct 17;272(42):26536-44. doi: 10.1074/jbc.272.42.26536. J Biol Chem. 1997. PMID: 9334232 Free article.

10

Structural bases of vasopressin/oxytocin receptor function.

Barberis C, Mouillac B, Durroux T. Barberis C, et al. Among authors: mouillac b. J Endocrinol. 1998 Feb;156(2):223-9. doi: 10.1677/joe.0.1560223. J Endocrinol. 1998. PMID: 9518866 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters